Inhibition of Histone Deacetylase 2 Facilitates Extinction of Aversive Memory
Invention type: Technology
/
Case number: #13759HBJRQ
The invention relates to methods and compositions for promoting cognitive function and/or treating cognitive function disorders and impairments. In particular the methods are accomplished by administering to a subject CI-994 or dinaline or a pharmaceutically acceptable salt, ester, prodrug or metabolite thereof.
Researchers
Li-Huei Tsai
/
Stephen Haggarty
/
Jisong Guan
/
Edward Holsen
/
Florence Wagner
/
Johannes Graff
Departments: DLC Heads Science
Technology Areas: Therapeutics: Small Molecules
Impact Areas: Healthy Living
-
use of ci-994 and dinaline for the treatment of memory/cognition and anxiety disorders
United States of America | Granted | 8,841,346
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.